Blockchain Registration Transaction Record

hyperCORE International Welcomes Empathx Clinical Research to Expand Trial Access

hyperCORE International partners with Empathx Clinical Research to expand clinical trial access across 6 US states, focusing on cardio-metabolic, CNS, nephrology & infectious disease research.

This partnership matters because it directly addresses critical barriers in clinical research that affect both patients and medical progress. By integrating clinical trials into existing healthcare settings through Empathx's hybrid model, patients gain easier access to potentially life-saving treatments without disrupting their regular care routines—particularly important for those with chronic conditions like cardio-metabolic diseases or CNS disorders. For pharmaceutical companies and researchers, the expanded geographic reach and diverse patient populations across six states mean faster enrollment and more representative trial results, accelerating the development of new therapies. In an era where clinical trial delays and lack of diversity in participants have been persistent problems, this collaboration demonstrates how strategic alliances between research networks can create more efficient, patient-centered approaches to medical innovation.